Takaichi Miwa

7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.

Tetsuro Kikuchi, Katsura Tottori, Yasufumi Uwahodo et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 275 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Involvement of σ1 receptors in methamphetamine-induced behavioral sensitization in rats

Shinji Takahashi, Takaichi Miwa, Kazutoshi Horikomi · Neuroscience Letters · 2000 · 62 citations

Life Sciences, Neuroscience, Pharmacology +14

Effects of antipsychotic polypharmacy on side‐effects and concurrent use of medications in schizophrenic outpatients

Yasuhiko Hashimoto, Junji Uno, Takaichi Miwa et al. · Psychiatry and Clinical Neurosciences · 2012 · 51 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for σ receptors

Shinji Takahashi, Kazuhiro Sonehara, Kaori Takagi et al. · Psychopharmacology · 1999 · 41 citations

Medicine, Pharmacology, Psychiatry +11

Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009

Takashi Yoshio, Toshiya Inada, Junji Uno et al. · Human Psychopharmacology Clinical and Experimental · 2012 · 28 citations

Pharmacy, Pharmacotherapy, Psychiatry +15